Dyphylline-associated follicle activation and PI3K/Akt dependence
Cell-based study · Ovaries isolated from 3-day-postpartum female ICR mice; organ culture [1]
Dyphylline increased growing follicle numbers and Akt phosphorylation. LY294002 blocked the follicle and signaling responses. Proliferation markers increased, while measured apoptosis markers showed no significant change. This is a tissue signaling experiment, without a direct PDE isoform inhibition measurement.
| Endpoint | Reported result | Reference |
|---|---|---|
| Growing follicle number versus medium control | direction Increased after 4 days | [1] |
| p-Akt and FOXO3a localization; pharmacological PI3K control | direction Increased p-Akt at 1 day and FOXO3a nuclear export at 2 days; LY294002 blocked responses and 4-day follicle activation | [1] |
| Ovarian cAMP versus control | direction Increased | [1] |
| BAX/BCL-2, cleaved caspase-3 and cleaved-caspase-3-positive cell counts | direction No significant effect compared with control | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 160 μM dyphylline for Figures 3–4; 10 μM LY294002 in Figure 4 inhibitor controls. Supplement Figure S4 cAMP-panel concentration not established from readable caption.
- Exposure duration
- 1 day for p-Akt; 2 days for FOXO3a and protein/immunofluorescence markers; 4 days for follicle counting; cAMP collection timing not established
- Method
- Organ culture in DMEM/F12; medium-alone control; LY294002-alone and dyphylline + LY294002 groups
- Vehicle
- Dyphylline stock in physiological saline; LY294002 stock in DMSO
- Co-treatment
- Dyphylline alone and dyphylline + LY294002; other theophylline derivatives were separate comparator groups
- Reported limits
- No dyphylline catalog number, purity or stereochemical composition specified. Exact vehicle matching/DMSO percentage and supplement cAMP collection timing/concentration not established; Figures 3–4 conditions are not assigned to the cAMP panel.
Methods and source locations
Compound reported in the paper: Dyphylline
Evidence applies to the named compound and stated model; stereochemical composition and Adooq lot equivalence were not established.
Figures 3A–I and 4A–I; Results: theophylline derivatives and PI3K/Akt; Supplement Figure S4E–F; Methods: ovary culture and shared analyses
Growing follicle number versus medium control: Histological follicle counting; n ≥ 3 biological replicates; mean ± SD; two-tailed unpaired t test. — Figure 3A–B and caption; Histological analysis and follicle counting
p-Akt and FOXO3a localization; pharmacological PI3K control: Western blotting, immunofluorescence and follicle counting; n ≥ 3 biological replicates; mean ± SD. — Figure 4A–I and caption
Ovarian cAMP versus control: ELISA; supplemental graphic reports mean ± SD; exact cAMP collection duration not established from readable caption. — Results paragraph beginning “Since many PDE subtypes”; Supplement Figure S4E (PDF page 5); Measurement of cAMP and cGMP levels
BAX/BCL-2, cleaved caspase-3 and cleaved-caspase-3-positive cell counts: qRT-PCR, western blotting and immunofluorescence at panel-specific 1- or 2-day time points. — Figure 3E–I and caption; Results: theophylline derivatives